Literature DB >> 11812854

Activation of p53 protein by telomeric (TTAGGG)n repeats.

M Milyavsky1, A Mimran, S Senderovich, I Zurer, N Erez, I Shats, N Goldfinger, I Cohen, V Rotter.   

Abstract

Genome instability is a primary factor leading to the activation of the p53 tumor suppressor protein. Telomeric repeat (TR) sequences are also responsible for genome integrity. By capping the termini of the chromosomes, TRs prevent them undergoing nucleolytic degradation, ligation or chromosome fusion. Interestingly, telomere shortening was suggested to activate p53, which in turn may cause primary cells to senesce. In order to elucidate the nature of a possible cross talk between the two, we introduced into cells TRs of defined length and investigated their effect on p53 activation and subsequent cellular response. We found that the introduction of a TR into cells leads to stabilization of the p53 protein. This stabilization was specific to TRs and was not observed in response to exposure of cells to plasmids containing non-TR sequences. p53 stabilization requires the presence of an intact p53 oligomerization domain. TR-activated p53 exhibited enhanced transcriptional activity. Eventually, TRs induced p53-dependent growth suppression, measured as a reduction in colony formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11812854      PMCID: PMC97590          DOI: 10.1093/nar/29.24.5207

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  81 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Telomere states and cell fates.

Authors:  E H Blackburn
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

3.  Recombination: a means to an end in human cells.

Authors:  S Smith
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

Review 4.  Signaling to p53: breaking the posttranslational modification code.

Authors:  E Appella; C W Anderson
Journal:  Pathol Biol (Paris)       Date:  2000-04

5.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

Authors:  R K Moyzis; J M Buckingham; L S Cram; M Dani; L L Deaven; M D Jones; J Meyne; R L Ratliff; J R Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.

Authors:  R Abdul-Ghani; P Ohana; I Matouk; S Ayesh; B Ayesh; M Laster; O Bibi; H Giladi; K Molnar-Kimber; M A Sughayer; N de Groot; A Hochberg
Journal:  Mol Ther       Date:  2000-12       Impact factor: 11.454

Review 7.  Regulation and function of the p53 tumor suppressor protein.

Authors:  K M Ryan; A C Phillips; K H Vousden
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

8.  p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Authors:  K Oda; H Arakawa; T Tanaka; K Matsuda; C Tanikawa; T Mori; H Nishimori; K Tamai; T Tokino; Y Nakamura; Y Taya
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  4 in total

1.  Senescence of primary amniotic cells via oxidative DNA damage.

Authors:  Ramkumar Menon; Istvan Boldogh; Rheanna Urrabaz-Garza; Jossimara Polettini; Tariq Ali Syed; George R Saade; John Papaconstantinou; Robert N Taylor
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

2.  TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Espen Burum-Auensen; Aasa R Schjølberg; Per Olaf Ekstrøm; Solveig N Andersen; Ole Petter Clausen; Paula M De Angelis
Journal:  Int J Mol Med       Date:  2014-10-20       Impact factor: 4.101

Review 3.  The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA.

Authors:  Alistair Rice; Armando Del Rio Hernandez
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

4.  Telomerase protects werner syndrome lineage-specific stem cells from premature aging.

Authors:  Hoi-Hung Cheung; Xiaozhuo Liu; Lucile Canterel-Thouennon; Lu Li; Catherine Edmonson; Owen M Rennert
Journal:  Stem Cell Reports       Date:  2014-03-27       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.